General
Australian biotech firm Vaxxas set for clinical trials of needle-free vaccine patches
Brisbane-based biotechnology company Vaxxas is set to launch clinical trials delivering a COVID-19 vaccine with needle-free patches from mid-next year.
Key points:
- Research shows the University of Texas Hexapro vaccine is effective against COVID-19 in mice when delivered with the Vaxxas patch
- UQ’s…
Continue Reading